OmegaCheck Panel

Your standard lipid panel measures cholesterol. But cholesterol is only one category of fat circulating in your blood. A separate family of fats, the omega fatty acids, plays a direct role in how much inflammation your body generates, how your blood vessels respond to stress, and how likely you are to die from heart disease. These fats are woven into the membranes of every cell in your body, and their balance tells a story that cholesterol numbers alone cannot.

This panel measures omega-3 and omega-6 fatty acids from a single blood draw, then calculates the ratios between them. A pooled analysis of 17 prospective cohort studies following roughly 42,000 people found that those with the highest blood levels of long-chain omega-3 fatty acids had about 15% to 18% lower risk of dying from any cause compared to those with the lowest levels. That signal is strong enough that some researchers have called the Omega-3 Index, which this panel includes, a risk predictor on par with smoking status.

What This Panel Reveals

The panel covers three clinical themes: your overall omega-3 status, the inflammatory tilt between omega-6 and omega-3 fats, and the individual levels of specific fatty acids that each carry distinct biological roles.

Overall Omega-3 Status

The OmegaCheck score reflects the combined percentage of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in your red blood cell membranes. Because red blood cells live about 120 days, this measurement reflects your average omega-3 intake over the past three to four months, not what you ate last week. This makes it far more stable and reliable than a dietary recall or a one-time blood draw.

An OmegaCheck (Omega-3 Index) below 4% places you in a high-risk zone for coronary heart disease. Between 4% and 8% is intermediate risk. At 8% or above, you reach the range associated with the greatest heart protection. The average American falls between 4% and 5%, well below the target. In Japan, where fish consumption is much higher, average values run between 8% and 11%, which tracks with Japan's historically lower rates of sudden cardiac death.

Inflammatory Balance

Omega-6 fatty acids are not inherently harmful. Your body needs them. But when the ratio of omega-6 to omega-3 tips too far toward omega-6, the biochemical environment shifts toward greater inflammation. The two ratio markers in this panel, the Omega-6:Omega-3 ratio and the AA:EPA ratio (arachidonic acid to eicosapentaenoic acid), quantify this balance.

The AA:EPA ratio is particularly telling. Arachidonic acid (an omega-6 fat) is the raw material your body uses to make chemicals that promote inflammation. EPA (an omega-3 fat) competes for the same enzymes and produces chemicals that help resolve inflammation instead. A high AA:EPA ratio means your body's inflammatory machinery is tilted toward producing more inflammation. In a Japanese study of patients undergoing coronary procedures, those with the lowest omega-3 to omega-6 fatty acid ratios had significantly higher rates of major cardiac events.

Individual Fatty Acid Levels

EPA and DHA are both omega-3 fats, but they serve different roles. EPA is the primary anti-inflammatory omega-3. It directly reduces the production of chemicals that promote inflammation and has been the focus of large cardiovascular trials. DHA is the dominant structural omega-3 in the brain and retina, where it helps keep cell membranes flexible, supports nerve signaling, and aids cognitive function.

DPA (docosapentaenoic acid) is the lesser-known third long-chain omega-3. In the Cardiovascular Health Study of older adults, higher plasma DPA levels were associated with roughly 23% lower risk of death from coronary heart disease. Because this panel measures DPA in red blood cell membranes rather than plasma, the values are not directly comparable, but both reflect underlying omega-3 status. DPA can convert into both EPA and DHA in the body, and emerging evidence suggests it has its own independent heart-protective effects.

Linoleic acid is the most abundant omega-6 fat in most diets, found in vegetable oils, nuts, and seeds. A meta-analysis of 13 prospective cohort studies including over 310,000 participants found that replacing saturated fat with linoleic acid was associated with a 9% lower risk of coronary heart disease events. Having linoleic acid on the panel lets you see both sides of the omega equation.

How to Read Your Results Together

No single number on this panel tells the full story. The value comes from reading the individual fatty acids alongside their ratios. Here are the key patterns to look for.

When Results Can Be Misleading

Because this panel measures fatty acids in red blood cell membranes, recent blood transfusions can skew results by introducing donor red blood cells with a different fatty acid profile. Very recent changes to diet or supplementation (within the past two to three weeks) will not yet be reflected in the results, since the measurement captures a months-long average.

Certain medications can also shift fatty acid levels. High-dose prescription omega-3 drugs (icosapent ethyl, for example) will raise EPA substantially and lower the AA:EPA ratio. If you are taking these medications, your results will reflect the drug effect, which is useful for monitoring but should be interpreted accordingly. Statin therapy does not meaningfully affect omega fatty acid levels.

Tracking Over Time

A single measurement is valuable, but serial testing adds another dimension. Two people taking the same fish oil supplement can end up with very different blood levels depending on genetics, gut absorption, body composition, and whether they take the supplement with a fat-containing meal. Without retesting, you cannot tell whether your strategy is working. Data from the Framingham Offspring Cohort suggests that people who maintain an Omega-3 Index above 8% over time may gain roughly five additional years of life expectancy compared to those who stay below 4%.

Putting Your Results to Work

Your results from this panel are directly actionable. A low OmegaCheck responds to increased EPA and DHA intake over three to four months. An elevated AA:EPA ratio, even alongside a reasonable OmegaCheck, suggests the imbalance lies on the omega-6 side of the equation. For the most complete cardiovascular risk picture, pair this panel with a lipid panel and hs-CRP (high-sensitivity C-reactive protein). When both hs-CRP and the AA:EPA ratio run high, the two tests reinforce the same signal: your body is producing more inflammation than your current fatty acid balance can counteract.